You’re exploring XERS as your free preview. Sign up free for 3 full 5D deep-dives a month, or start a 14-day Pro trial for unlimited access to more than 3,000 US-listed stocks - no credit card.

Xeris Biopharma Holdings, Inc.· XERS

🇺🇸 US · SmallBroad USNASDAQ

Healthcare Biotechnology Website

Price: $10.48
Day: +2.85%
Mkt Cap: $1.81B
52W Range: $5.25 – $11.33
Volume: 2.71M
Beta: 0.84

D35D Framework

Valuation Analysis

Intrinsic-value engines paired with peer-anchored multiples.

Valuation: 1.0 / 5 (Well above estimate); at $10.48 the price is 148% above the blended estimate of $4
Estimates: sector peers $4 (166 companies), own 10-year history $11
Multiples: EV/EBITDA 119.2x vs sector median 11.7x

Blog

Valuation Assessment

XERS Valuation Summary

How sector peers and the stock's own history value it (no intrinsic model available for this stock)

Overall valuation

1.0/5

Well above estimate

Market only · blended estimate

$4-59.7%

Based on the market evidence from peers and the stock's own history, the price is 148% above the market estimate.Last updated October 11, 2026.

Valuation Multiples

Per-metric breakdown of how XERS is priced relative to its sector peers, its own 10-year history, and analyst forward estimates.

Valuation context: Operates with thin profit margins. All five primary multiples remain useful; revenue multiples (P/S, EV/Sales) in the expanded section provide additional context on margin trends.

What sector peers imply

Value if it traded at the sector-median multiple

What its own history implies

Value if it traded at its own 10-year median multiple

How the Multiples lens works

Five primary multiples surface the headline call; five additional multiples sit one click deeper for context.

Valuation multiples compare a company's market price to its financial fundamentals. The primary grid covers both the equity perspective (P/E, PEG, FCF Yield) and the enterprise value perspective (EV/EBITDA, EV/FCF) so you see how the market prices the company two ways simultaneously.

Price-based multiples use market cap and reflect what equity investors pay. EV-based multiples include debt and are better for comparing companies with different capital structures. The expanded section below adds P/B, P/S, P/FCF, EV/EBIT, and EV/Sales for additional perspective.

Learn more about the 5D valuation methodology

Xeris Biopharma Holdings, Inc.· XERS

Valuation Analysis

Valuation Multiples

Additional valuation multiples5 more metrics: P/B Ratio, P/S Ratio, P/FCF, EV/EBIT, EV/Sales

How implied prices are calculated

Primary multiples primer

Search stocks

Valuation Analysis

Valuation Multiples

Additional valuation multiples5 more metrics: P/B Ratio, P/S Ratio, P/FCF, EV/EBIT, EV/Sales

How implied prices are calculated

Primary multiples primer